Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Phosphoribosylaminoimidazole carboxylase, phosphoribosylaminoimidazole succinocarboxamide synthetase pseudogene 4" (PAICSP4) is annotated as a pseudogene, not as a functional protein-coding gene. It is derived from genes involved in purine biosynthesis (likely from genes PAICS or similar), but does not produce a functional product and is not considered a therapeutic target, enzyme, receptor, transporter, or other druggable molecule. It has no defined molecular function, disease association, or pharmacological relevance. Its listing as a combined, compound name followed by "pseudogene 4" strongly suggests a database artifact, misannotation, or a nonstandard entry. If you require detailed information on the actual enzymes (not the pseudogene) from which this pseudogene is derived—such as phosphoribosylaminoimidazole carboxylase or phosphoribosylaminoimidazole succinocarboxamide synthetase—please specify, as those are functional enzymes in purine biosynthesis.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Phosphoribosylaminoimidazole carboxylase, phosphoribosylaminoimidazole succinocarboxamide synthetase pseudogene 4 (PAICSP4).